Cargando…
Guillain-Barre syndrome in 220 patients with COVID-19
This review summarises and discusses recent findings concerning the pathophysiology, clinical presentation, diagnosis, treatment, and outcome of SARS-CoV-2-associated Guillain-Barre syndrome (SC2-GBS). By the end of December 2020, at least 220 patients with SC2-GBS have been published in 95 papers....
Autores principales: | Finsterer, Josef, Scorza, Fulvio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094972/ https://www.ncbi.nlm.nih.gov/pubmed/33967575 http://dx.doi.org/10.1186/s41983-021-00310-7 |
Ejemplares similares
-
Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022) -
Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
por: Finsterer, Josef, et al.
Publicado: (2021) -
Guillain–Barre syndrome with pleocytosis requires workup for cerebral disease
por: Finsterer, Josef, et al.
Publicado: (2023) -
SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome
por: Finsterer, Josef, et al.
Publicado: (2022) -
SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)